Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2020 | 08-2019 | 08-2018 | 08-2017 | 12-2016 | |
| Operating Expenses | 4,686 | 3,210 | 2,344 | 233 | 233 |
| Operating Income | -4,686 | -3,210 | -2,344 | -233 | -233 |
| Interest Expense | 1 | 0 | 0 | 2 | 2 |
| Other Income | 32 | 1,037 | 0 | 0 | 0 |
| Pre-tax Income | -4,655 | -2,172 | -2,344 | -235 | -235 |
| Net Income Continuous | -4,655 | -2,172 | -2,344 | -235 | -235 |
| Net Income | $-4,655 | $-2,172 | $-2,344 | $-235 | $-235 |
| EPS Basic Total Ops | -340.00 | -269.84 | -496.50 | -8.10 | N/A |
| EPS Basic Continuous Ops | -338.79 | -269.80 | -494.99 | -7.26 | N/A |
| EPS Diluted Total Ops | -340.00 | -269.84 | -496.50 | -8.10 | N/A |
| EPS Diluted Continuous Ops | -338.79 | -269.80 | -494.99 | -7.26 | N/A |
| EBITDA(a) | $-4,686 | $-3,209 | $-2,343 | $-232 | $-233 |